IDO1 and head and neck squamous cell carcinoma: A systematic review assessed 40 clinical studies to elucidate the role of indoleamine 2,3‐dioxygenase (IDO), a key intracellular enzyme involved in immune regulation, in HNSCC and found that its immunohistochemical expression was correlated with worse survival.